Quite a few patients affected by hidradenitis suppurativa/acne inversa suffer from disease manifestations long before targeted therapeutic measures are taken. There are various reasons for this. One approach to tackling the problem of diagnostic latency is to increase awareness and improve interdisciplinary networking. The evidence base and treatment options have expanded considerably in recent times. In the case of biologics, there are now several active substances to choose from and there have also been some innovations in antibiotics.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Follow-up care for head and neck cancer
What is the significance of FDG PET-CT?
- Important basics and studies on cancer and the psyche
Interplay between cancer and mental illness
- Systemic lupus erythematosus
Increased risk of pulmonary manifestations
- Postmenopausal osteoporosis: long-term therapy concepts
Targeted use of antiresorptives and osteoanabolic agents and avoid “rebound” effects
- Late-onset rheumatoid arthritis
More DMARDs can reduce glucocorticoids in LORA
- Atopic dermatitis
Implement the “minimal disease activity” concept
- Sensation of pain
Special features for people with multiple disabilities
- Atopic dermatitis